Covea Finance grew its holdings in shares of Xylem Inc. (NYSE:XYL – Free Report) by 38.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 106,286 shares of the industrial products company’s stock after purchasing an additional 29,600 shares during the quarter. Covea Finance’s holdings in Xylem were worth $12,331,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also recently made changes to their positions in the business. State Street Corp increased its holdings in Xylem by 1.9% during the third quarter. State Street Corp now owns 10,329,494 shares of the industrial products company’s stock valued at $1,394,792,000 after buying an additional 189,820 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Xylem by 1.0% during the 3rd quarter. Geode Capital Management LLC now owns 5,668,755 shares of the industrial products company’s stock valued at $762,804,000 after acquiring an additional 54,877 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Xylem by 1.0% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,449,307 shares of the industrial products company’s stock worth $465,760,000 after purchasing an additional 32,645 shares in the last quarter. Swedbank AB raised its holdings in Xylem by 22.8% in the 3rd quarter. Swedbank AB now owns 2,991,583 shares of the industrial products company’s stock worth $403,953,000 after purchasing an additional 554,609 shares during the period. Finally, Impax Asset Management Group plc lifted its position in Xylem by 1.0% during the third quarter. Impax Asset Management Group plc now owns 1,677,816 shares of the industrial products company’s stock valued at $226,555,000 after purchasing an additional 15,825 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.
Xylem Trading Down 0.1 %
Shares of XYL stock opened at $115.48 on Wednesday. The stock’s 50-day moving average price is $121.55 and its 200-day moving average price is $129.20. Xylem Inc. has a 12-month low of $109.39 and a 12-month high of $146.08. The stock has a market capitalization of $28.06 billion, a price-to-earnings ratio of 33.77, a price-to-earnings-growth ratio of 2.22 and a beta of 1.06. The company has a current ratio of 1.96, a quick ratio of 1.42 and a debt-to-equity ratio of 0.19.
Xylem Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 24th. Investors of record on Tuesday, November 26th were given a $0.36 dividend. The ex-dividend date was Tuesday, November 26th. This represents a $1.44 dividend on an annualized basis and a yield of 1.25%. Xylem’s dividend payout ratio is presently 42.11%.
Wall Street Analyst Weigh In
A number of analysts have commented on the company. Royal Bank of Canada reduced their price target on Xylem from $163.00 to $162.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Citigroup decreased their target price on shares of Xylem from $148.00 to $147.00 and set a “buy” rating on the stock in a research note on Monday. Stifel Nicolaus dropped their price target on shares of Xylem from $172.00 to $166.00 and set a “buy” rating for the company in a research report on Wednesday, December 11th. Wolfe Research restated a “peer perform” rating on shares of Xylem in a research report on Thursday, December 12th. Finally, Robert W. Baird lowered their target price on shares of Xylem from $175.00 to $154.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat, Xylem currently has an average rating of “Moderate Buy” and an average price target of $152.10.
View Our Latest Analysis on XYL
About Xylem
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Stories
- Five stocks we like better than Xylem
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 3 REITs With Big Dividend Growth and Sustainable Payouts
- Why Invest in 5G? How to Invest in 5G Stocks
- Can Integrated Healthcare Stocks Succeed in Public Markets?
- The 3 Best Fintech Stocks to Buy Now
- What Lucid’s Partnership With SoundHound Means for LCID Stock
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.